American College of Toxicology 40th Annual Meeting

Meet with our Business Development and Toxicology leadership at the 40th Annual Meeting of the American College of Toxicology.

Learn about our capabilities in immuno-oncology and gene therapy toxicology to effectively move new therapeutics towards the clinic. Our infectious disease group provides a long history of immunoassay, immunoprofiling, microbiology, and virology experience to precisely monitor the immune response elicited from emerging therapeutic approaches.

Request a meeting with our attending staff:
William Johnson, PhD, DABT, Toxicology Division Manager
Todd Bucciarelli, MBA, Director of Business Development